Cell Source, Inc. (CLCS) Operating income 2017–2024
Cell Source, Inc. (CLCS) annual operating income history from SEC filings — each fiscal year as reported.
-$3.8MFY2024 · since FY2017: -$2.3M → -$3.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$3.8M | +11.2% |
| FY2023 | -$4.3M | -3.6% |
| FY2022 | -$4.2M | -3.9% |
| FY2021 | -$4.0M | -10.5% |
| FY2020 | -$3.6M | +4.4% |
| FY2019 | -$3.8M | -89.7% |
| FY2018 | -$2.0M | +12.5% |
| FY2017 | -$2.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice